Evidence map›Paper›PMID 36197347›Full record

ArticleRevista do Colegio Brasileiro de Cirurgioes2022

Safety and efficacy of roux-en-y gastric bypass in older aged patients.

Jorge Humberto Rodriguez Quintero, Rachel Grosser, Gustavo Romero Velez, Vicente Omar Ramos-Santillan, Xavier Pereira, Fernando Muñoz Flores, Jenny Choi, Erin Moran-Atkin, Diego Camacho, Diego Laurentino Lima

Erratum issuedAbstract read
In one paragraph

Article in Revista do Colegio Brasileiro de Cirurgioes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Jorge Humberto Rodriguez Quintero- Montefiore Medical Center, Surgery - The Bronx - New York - Estados Unidos.ORCID http://orcid.org/0000-0002-6584-7945
Rachel Grosser- Montefiore Medical Center, Surgery - The Bronx - New York - Estados Unidos.
Gustavo Romero Velez- Montefiore Medical Center, Surgery - The Bronx - New York - Estados Unidos.ORCID http://orcid.org/0000-0002-9762-3698
Vicente Omar Ramos-Santillan- Montefiore Medical Center, Surgery - The Bronx - New York - Estados Unidos.ORCID http://orcid.org/0000-0002-0286-5126
Xavier Pereira- Montefiore Medical Center, Surgery - The Bronx - New York - Estados Unidos.ORCID http://orcid.org/0000-0001-6247-7523
Fernando Muñoz Flores- Montefiore Medical Center, Surgery - The Bronx - New York - Estados Unidos.ORCID http://orcid.org/0000-0003-3873-4897
Jenny Choi- Montefiore Medical Center, Surgery - The Bronx - New York - Estados Unidos.
Erin Moran-Atkin- Montefiore Medical Center, Surgery - The Bronx - New York - Estados Unidos.
Diego Camacho- Montefiore Medical Center, Surgery - The Bronx - New York - Estados Unidos.
Diego Laurentino Lima- Montefiore Medical Center, Surgery - The Bronx - New York - Estados Unidos.ORCID http://orcid.org/0000-0001-7383-1284

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionlaparoscopic Roux-en-Y Gastric Bypass (LRYGB) has been a revolutionary intervention for weight loss with reduction of up to 60-70% of excess body weight. However, these outcomes are not as well validated at the extremes of age, where the safety of the intervention still has some caveats. The aim of this study is to assess the efficacy and safety of primary LRYGB among different age groups.

methodsthe Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database was queried for patients who underwent primary LRYGB from January 2014 to December 2017 at a single institution. Four groups were created and compared by dividing our sample by age quartiles. The primary outcome was percent excess weight loss (%EWL) at 1 year. Additional operative outcomes and complications were also compared across groups.

resultsa total of 1013 patients underwent non-revisional LRYGB during the study period. Mean %EWL at one year was 55%. When compared between quartiles, there was a statistically significant difference in %EWL: 1st 62%, 2nd 57%, 3rd 54% and 4th 47% (p=0.010). The differences in the secondary outcomes between age groups did not demonstrate statistical significance.

conclusionsthough patients in the fourth age quartile (range) did not demonstrate a statistically significant increase in adverse outcomes, they did lose less weight compared to other cohorts. The %EWL at one year after RYGB varied by age in our cohort. Goals after bariatric surgery should be individualized as weight loss is less robust with aging.

Indexed as

Bariatric SurgeryGastric BypassLaparoscopyObesity, MorbidAgedGastrectomyHumansMiddle AgedRetrospective StudiesTreatment OutcomeWeight Loss

Identifiers

PMID36197347
PMCPMC10578815

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.